E2Pi Publications
Country Profiles of European Donor Governments
Sabine Campe, Meghan Reidy, Christina Schrade, Gavin Yamey, May 2011
E2Pi has published country profiles of global health policymaking in the United Kingdom, Germany, and France, three of the largest European donors. The profiles provide an overview of each country’s political system and decision-making processes, including summaries of current global health strategies and funding commitments.
Reports
Estimating Benchmarks of Success in the Affordable Medicines Facility—malaria (AMFm) Phase 1
Marco Schäferhoff, Gavin Yamey, January 2011
E2Pi was contracted by the Global Fund to examine the crucial question facing the AMFm pilot of what constitutes “success” at one year. Results were presented at the 22nd meeting of the Global Fund Board in December 2010.
Policy Briefings
The Health Systems Funding Platform - A Primer
Marco Schäferhoff, Christina Schrade, Gavin Yamey, March 2011
The GAVI Alliance, the Global Fund to Fight AIDS, Tuberculosis and Malaria, and the World Bank are developing a Health Systems Funding Platform to coordinate aid to health systems. E2Pi’s Policy Brief discusses the Platform’s objectives and operational framework, the current status of its implementation, and the challenges it faces.
Working Paper
Christina Schrade, Gavin Yamey, Marco Schäferhoff, December 2010
At its December meeting, the Board of the Global Fund to Fight AIDS, Tuberculosis and Malaria (GF) will discuss whether the GF should increase its support for MNCH. E2Pi's working paper “deconstructs” MNCH to explore which MNCH packages and interventions the GF might be well placed to support.
Journal Articles
Piloting the Affordable Medicines Facility - malaria: what will “success” look like?
Yamey G, Schäferhoff M, Montagu D. Bulletin of the WHO; March 2012 (in press)
The Affordable Medicines Facility-malaria (AMFm) is an innovative financing mechanism, managed by the Global Fund to Fight AIDS, Tuberculosis and Malaria, to increase the use of artemisinin-based combination therapies for treating malaria. To evaluate the AMFm pilot in eight countries, E2Pi conducted an analysis estimating predetermined “benchmarks” of success at 1 and 2 years.
Marco Schäferhoff, Christina Schrade, Gavin Yamey, PLoS Medicine, July 2010
E2Pi analyzes estimates of current spending on maternal, newborn and child health (MNCH) and of how much additional funding is needed to reach global MNCH goals. Accurate estimates are a critical precondition for sound policy and decision making in MNCH. E2Pi argues that the $30bn “price tag” of additional funding needed to save the lives of over 10 million women and children by 2015—cited in the Consensus for Maternal, Newborn and Child Health and elsewhere—is misleading because it leaves out crucial service delivery costs. The article makes several recommendations for improving both the tracking of MNCH financing flows and the estimation of additional MNCH resources required to reach the child and maternal millennium development goals (MDGs).
A Moment of Truth for Global Health
Richard Feachem, Gavin Yamey, Christina Schrade, BMJ, June 2010
E2Pi argues that, in response to the economic downturn and potential funding shortfalls, the different “silos” working in the global health community should come together and agree on a “cross cutting” agenda. Such an agenda should focus on how to get the overall global health architecture right and how to ensure maximum return for every dollar invested by tackling four key areas.
Other Publications
"Progress Sheets for the Living Proof Project"
Prior to its official launch, E2Pi produced a series of briefings summarizing evidence of progress in tackling eight global health priorities (HIV/AIDS, tuberculosis, malaria, polio, immunization, maternal/newborn/child health, nutrition, and neglected tropical diseases). These progess sheets provided critical evidence to support the Living Proof Project a major global health communications and advocacy campaign spearheaded by the Bill & Melinda Gates Foundation, which aims to sustain and increase investments in global health.